TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Scanbio Ingredients AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
793,560
|
638,555
|
507,011 |
Financial expenses |
117,295
|
80,973
|
64,776 |
Earnings before taxes |
112,160
|
-20,734
|
14,164 |
Total assets |
568,353
|
363,565
|
352,794 |
Current assets |
435,584
|
217,391
|
173,943 |
Current liabilities |
195,731
|
161,726
|
157,438 |
Equity capital |
371,886
|
201,839
|
194,200 |
- share capital |
251,609
|
244,047
|
227,186 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
65.4%
|
55.5%
|
55.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
14.1%
|
-3.2%
|
2.8% |
Return on assets (ROA) |
40.4%
|
16.6%
|
22.4% |
Current ratio |
222.5%
|
134.4%
|
110.5% |
Return on equity (ROE) |
30.2%
|
-10.3%
|
7.3% |
Change turnover |
135,219
|
93,915
|
19,888 |
Change turnover % |
21%
|
17%
|
4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.